Global Single-Use Technology for Biopharmaceuticals Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Single-Use Technology for Biopharmaceuticals market size was valued at US$ 5871 million in 2025 and is forecast to a readjusted size of US$ 11118 million by 2032 with a CAGR of 9.7% during review period.
Single-Use Technology for Biopharmaceuticals refers to disposable bioprocessing systems, components, and consumables used in the development and manufacturing of biopharmaceutical products. These technologies are designed to be used for a single production batch, process step, or manufacturing campaign and then discarded, replacing traditional stainless-steel systems that require cleaning, sterilization, and validation.
In the biopharmaceutical industry, single-use technology typically includes single-use bioreactors, media and buffer bags, storage bags, mixing systems, tubing assemblies, sterile connectors, filters, sampling systems, sensors, and fill-finish assemblies. These products are widely used in upstream processing, downstream processing, fluid management, formulation, and aseptic transfer for the production of monoclonal antibodies, vaccines, recombinant proteins, cell therapies, gene therapies, mRNA products, and other biologics.
The single-use technology for biopharmaceutical sector is characterized by high gross margins; leading international companies maintain gross margins exceeding 50% thanks to technological barriers and brand advantages.
Single-use technology in biopharmaceuticals is rapidly evolving toward greater intelligence, modularity, and sustainability. Future trends include 'smart single-use systems'?integrating sensors and IoT technology?to enable real-time process monitoring and digital control; modular facility designs that shorten construction timelines and enhance production flexibility; and customized single-use solutions tailored for emerging therapies such as mRNA and cell and gene therapies. Regarding sustainability, the industry is shifting from traditional plastics to bio-based, biodegradable materials while simultaneously reducing waste through closed-loop recycling systems.
In terms of raw materials, multi-layer co-extruded films (e.g., polyethylene, EVOH barrier layers), silicone tubing, and thermoplastic elastomers (TPE) remain dominant; however, the supply chain is undergoing profound transformation. There is a heavy reliance on a limited number of European and American suppliers (such as Thermo Fisher, Sartorius, and Merck) for key resins and films, though geopolitical factors and the post-pandemic landscape are driving a diversification of global production capacity. Chinese enterprises are accelerating efforts to achieve import substitution for high-end films and precision connectors. Furthermore, increasingly stringent standards for extractables and leachables (E&L) are pushing raw materials toward higher purity, lower adsorption, and reduced particle shedding, with biocompatibility certifications (e.g., USP Class VI, ISO 10993) becoming essential market entry requirements.
This report is a detailed and comprehensive analysis for global Single-Use Technology for Biopharmaceuticals market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Single-Use Technology for Biopharmaceuticals market size and forecasts, in consumption value ($ Million), 2021-2032
Global Single-Use Technology for Biopharmaceuticals market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Single-Use Technology for Biopharmaceuticals market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Single-Use Technology for Biopharmaceuticals market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Single-Use Technology for Biopharmaceuticals market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Single-Use Technology for Biopharmaceuticals product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Single-Use Technology for Biopharmaceuticals, with revenue, gross margin, and global market share of Single-Use Technology for Biopharmaceuticals from 2021 to 2026.
Chapter 3, the Single-Use Technology for Biopharmaceuticals competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Single-Use Technology for Biopharmaceuticals market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Single-Use Technology for Biopharmaceuticals.
Chapter 13, to describe Single-Use Technology for Biopharmaceuticals research findings and conclusion.
Single-Use Technology for Biopharmaceuticals refers to disposable bioprocessing systems, components, and consumables used in the development and manufacturing of biopharmaceutical products. These technologies are designed to be used for a single production batch, process step, or manufacturing campaign and then discarded, replacing traditional stainless-steel systems that require cleaning, sterilization, and validation.
In the biopharmaceutical industry, single-use technology typically includes single-use bioreactors, media and buffer bags, storage bags, mixing systems, tubing assemblies, sterile connectors, filters, sampling systems, sensors, and fill-finish assemblies. These products are widely used in upstream processing, downstream processing, fluid management, formulation, and aseptic transfer for the production of monoclonal antibodies, vaccines, recombinant proteins, cell therapies, gene therapies, mRNA products, and other biologics.
The single-use technology for biopharmaceutical sector is characterized by high gross margins; leading international companies maintain gross margins exceeding 50% thanks to technological barriers and brand advantages.
Single-use technology in biopharmaceuticals is rapidly evolving toward greater intelligence, modularity, and sustainability. Future trends include 'smart single-use systems'?integrating sensors and IoT technology?to enable real-time process monitoring and digital control; modular facility designs that shorten construction timelines and enhance production flexibility; and customized single-use solutions tailored for emerging therapies such as mRNA and cell and gene therapies. Regarding sustainability, the industry is shifting from traditional plastics to bio-based, biodegradable materials while simultaneously reducing waste through closed-loop recycling systems.
In terms of raw materials, multi-layer co-extruded films (e.g., polyethylene, EVOH barrier layers), silicone tubing, and thermoplastic elastomers (TPE) remain dominant; however, the supply chain is undergoing profound transformation. There is a heavy reliance on a limited number of European and American suppliers (such as Thermo Fisher, Sartorius, and Merck) for key resins and films, though geopolitical factors and the post-pandemic landscape are driving a diversification of global production capacity. Chinese enterprises are accelerating efforts to achieve import substitution for high-end films and precision connectors. Furthermore, increasingly stringent standards for extractables and leachables (E&L) are pushing raw materials toward higher purity, lower adsorption, and reduced particle shedding, with biocompatibility certifications (e.g., USP Class VI, ISO 10993) becoming essential market entry requirements.
This report is a detailed and comprehensive analysis for global Single-Use Technology for Biopharmaceuticals market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Single-Use Technology for Biopharmaceuticals market size and forecasts, in consumption value ($ Million), 2021-2032
Global Single-Use Technology for Biopharmaceuticals market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Single-Use Technology for Biopharmaceuticals market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Single-Use Technology for Biopharmaceuticals market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Single-Use Technology for Biopharmaceuticals
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Single-Use Technology for Biopharmaceuticals market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Single-use Bioreactors
- Single-use Bags & Containers
- Filtration Assemblies
- Tubing & Connectors
- Others
- Biopharmaceutical Companies
- CDMOs / CMOs
- Research Institutes
- Cell & Gene Therapy Companies
- Vaccine Manufacturers
- <50 L
- 50?500 L
- 500?1,000 L
- >1,000 L
- Monoclonal Antibodies
- Vaccines
- Cell & Gene Therapy
- Recombinant Proteins
- Others
- Danaher (US)
- Sartorius (DE)
- Thermo Fisher Scientific (US)
- Merck KGaA (DE)
- Repligen (US)
- Meissner Filtration Products (US)
- ABEC (US)
- Avantor (US)
- Corning (US)
- Entegris (US)
- Saint-Gobain Life Sciences (FR)
- Watson-Marlow / BioPure (GB)
- CPC / Colder Products (US)
- Eppendorf (DE)
- Getinge / Applikon (SE)
- PBS Biotech (US)
- Shanghai Tofflon Science and Technology Co., Ltd. (CN)
- Shanghai LePure Biotech Co., Ltd. (CN)
- Shanghai Duoning Biotechnology Co., Ltd. (CN)
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Single-Use Technology for Biopharmaceuticals product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Single-Use Technology for Biopharmaceuticals, with revenue, gross margin, and global market share of Single-Use Technology for Biopharmaceuticals from 2021 to 2026.
Chapter 3, the Single-Use Technology for Biopharmaceuticals competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Single-Use Technology for Biopharmaceuticals market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Single-Use Technology for Biopharmaceuticals.
Chapter 13, to describe Single-Use Technology for Biopharmaceuticals research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Single-Use Technology for Biopharmaceuticals by Type
1.3.1 Overview: Global Single-Use Technology for Biopharmaceuticals Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Type in 2025
1.3.3 Single-use Bioreactors
1.3.4 Single-use Bags & Containers
1.3.5 Filtration Assemblies
1.3.6 Tubing & Connectors
1.3.7 Others
1.4 Classification of Single-Use Technology for Biopharmaceuticals by End User
1.4.1 Overview: Global Single-Use Technology for Biopharmaceuticals Market Size by End User: 2021 Versus 2025 Versus 2032
1.4.2 Global Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by End User in 2025
1.4.3 Biopharmaceutical Companies
1.4.4 CDMOs / CMOs
1.4.5 Research Institutes
1.4.6 Cell & Gene Therapy Companies
1.4.7 Vaccine Manufacturers
1.5 Classification of Single-Use Technology for Biopharmaceuticals by Scale of Operation
1.5.1 Overview: Global Single-Use Technology for Biopharmaceuticals Market Size by Scale of Operation: 2021 Versus 2025 Versus 2032
1.5.2 Global Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Scale of Operation in 2025
1.5.3 <50 L
1.5.4 50?500 L
1.5.5 500?1,000 L
1.5.6 >1,000 L
1.6 Global Single-Use Technology for Biopharmaceuticals Market by Application
1.6.1 Overview: Global Single-Use Technology for Biopharmaceuticals Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Monoclonal Antibodies
1.6.3 Vaccines
1.6.4 Cell & Gene Therapy
1.6.5 Recombinant Proteins
1.6.6 Others
1.7 Global Single-Use Technology for Biopharmaceuticals Market Size & Forecast
1.8 Global Single-Use Technology for Biopharmaceuticals Market Size and Forecast by Region
1.8.1 Global Single-Use Technology for Biopharmaceuticals Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Single-Use Technology for Biopharmaceuticals Market Size by Region, (2021-2032)
1.8.3 North America Single-Use Technology for Biopharmaceuticals Market Size and Prospect (2021-2032)
1.8.4 Europe Single-Use Technology for Biopharmaceuticals Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Single-Use Technology for Biopharmaceuticals Market Size and Prospect (2021-2032)
1.8.6 South America Single-Use Technology for Biopharmaceuticals Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Single-Use Technology for Biopharmaceuticals Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Danaher (US)
2.1.1 Danaher (US) Details
2.1.2 Danaher (US) Major Business
2.1.3 Danaher (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.1.4 Danaher (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Danaher (US) Recent Developments and Future Plans
2.2 Sartorius (DE)
2.2.1 Sartorius (DE) Details
2.2.2 Sartorius (DE) Major Business
2.2.3 Sartorius (DE) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.2.4 Sartorius (DE) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Sartorius (DE) Recent Developments and Future Plans
2.3 Thermo Fisher Scientific (US)
2.3.1 Thermo Fisher Scientific (US) Details
2.3.2 Thermo Fisher Scientific (US) Major Business
2.3.3 Thermo Fisher Scientific (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.3.4 Thermo Fisher Scientific (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Thermo Fisher Scientific (US) Recent Developments and Future Plans
2.4 Merck KGaA (DE)
2.4.1 Merck KGaA (DE) Details
2.4.2 Merck KGaA (DE) Major Business
2.4.3 Merck KGaA (DE) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.4.4 Merck KGaA (DE) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Merck KGaA (DE) Recent Developments and Future Plans
2.5 Repligen (US)
2.5.1 Repligen (US) Details
2.5.2 Repligen (US) Major Business
2.5.3 Repligen (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.5.4 Repligen (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Repligen (US) Recent Developments and Future Plans
2.6 Meissner Filtration Products (US)
2.6.1 Meissner Filtration Products (US) Details
2.6.2 Meissner Filtration Products (US) Major Business
2.6.3 Meissner Filtration Products (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.6.4 Meissner Filtration Products (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Meissner Filtration Products (US) Recent Developments and Future Plans
2.7 ABEC (US)
2.7.1 ABEC (US) Details
2.7.2 ABEC (US) Major Business
2.7.3 ABEC (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.7.4 ABEC (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 ABEC (US) Recent Developments and Future Plans
2.8 Avantor (US)
2.8.1 Avantor (US) Details
2.8.2 Avantor (US) Major Business
2.8.3 Avantor (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.8.4 Avantor (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Avantor (US) Recent Developments and Future Plans
2.9 Corning (US)
2.9.1 Corning (US) Details
2.9.2 Corning (US) Major Business
2.9.3 Corning (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.9.4 Corning (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Corning (US) Recent Developments and Future Plans
2.10 Entegris (US)
2.10.1 Entegris (US) Details
2.10.2 Entegris (US) Major Business
2.10.3 Entegris (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.10.4 Entegris (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Entegris (US) Recent Developments and Future Plans
2.11 Saint-Gobain Life Sciences (FR)
2.11.1 Saint-Gobain Life Sciences (FR) Details
2.11.2 Saint-Gobain Life Sciences (FR) Major Business
2.11.3 Saint-Gobain Life Sciences (FR) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.11.4 Saint-Gobain Life Sciences (FR) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Saint-Gobain Life Sciences (FR) Recent Developments and Future Plans
2.12 Watson-Marlow / BioPure (GB)
2.12.1 Watson-Marlow / BioPure (GB) Details
2.12.2 Watson-Marlow / BioPure (GB) Major Business
2.12.3 Watson-Marlow / BioPure (GB) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.12.4 Watson-Marlow / BioPure (GB) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Watson-Marlow / BioPure (GB) Recent Developments and Future Plans
2.13 CPC / Colder Products (US)
2.13.1 CPC / Colder Products (US) Details
2.13.2 CPC / Colder Products (US) Major Business
2.13.3 CPC / Colder Products (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.13.4 CPC / Colder Products (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 CPC / Colder Products (US) Recent Developments and Future Plans
2.14 Eppendorf (DE)
2.14.1 Eppendorf (DE) Details
2.14.2 Eppendorf (DE) Major Business
2.14.3 Eppendorf (DE) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.14.4 Eppendorf (DE) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Eppendorf (DE) Recent Developments and Future Plans
2.15 Getinge / Applikon (SE)
2.15.1 Getinge / Applikon (SE) Details
2.15.2 Getinge / Applikon (SE) Major Business
2.15.3 Getinge / Applikon (SE) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.15.4 Getinge / Applikon (SE) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Getinge / Applikon (SE) Recent Developments and Future Plans
2.16 PBS Biotech (US)
2.16.1 PBS Biotech (US) Details
2.16.2 PBS Biotech (US) Major Business
2.16.3 PBS Biotech (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.16.4 PBS Biotech (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 PBS Biotech (US) Recent Developments and Future Plans
2.17 Shanghai Tofflon Science and Technology Co., Ltd. (CN)
2.17.1 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Details
2.17.2 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Major Business
2.17.3 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.17.4 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Recent Developments and Future Plans
2.18 Shanghai LePure Biotech Co., Ltd. (CN)
2.18.1 Shanghai LePure Biotech Co., Ltd. (CN) Details
2.18.2 Shanghai LePure Biotech Co., Ltd. (CN) Major Business
2.18.3 Shanghai LePure Biotech Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.18.4 Shanghai LePure Biotech Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Shanghai LePure Biotech Co., Ltd. (CN) Recent Developments and Future Plans
2.19 Shanghai Duoning Biotechnology Co., Ltd. (CN)
2.19.1 Shanghai Duoning Biotechnology Co., Ltd. (CN) Details
2.19.2 Shanghai Duoning Biotechnology Co., Ltd. (CN) Major Business
2.19.3 Shanghai Duoning Biotechnology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.19.4 Shanghai Duoning Biotechnology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Shanghai Duoning Biotechnology Co., Ltd. (CN) Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Single-Use Technology for Biopharmaceuticals Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Single-Use Technology for Biopharmaceuticals by Company Revenue
3.2.2 Top 3 Single-Use Technology for Biopharmaceuticals Players Market Share in 2025
3.2.3 Top 6 Single-Use Technology for Biopharmaceuticals Players Market Share in 2025
3.3 Single-Use Technology for Biopharmaceuticals Market: Overall Company Footprint Analysis
3.3.1 Single-Use Technology for Biopharmaceuticals Market: Region Footprint
3.3.2 Single-Use Technology for Biopharmaceuticals Market: Company Product Type Footprint
3.3.3 Single-Use Technology for Biopharmaceuticals Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Single-Use Technology for Biopharmaceuticals Consumption Value and Market Share by Type (2021-2026)
4.2 Global Single-Use Technology for Biopharmaceuticals Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Application (2021-2026)
5.2 Global Single-Use Technology for Biopharmaceuticals Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2021-2032)
6.2 North America Single-Use Technology for Biopharmaceuticals Market Size by Application (2021-2032)
6.3 North America Single-Use Technology for Biopharmaceuticals Market Size by Country
6.3.1 North America Single-Use Technology for Biopharmaceuticals Consumption Value by Country (2021-2032)
6.3.2 United States Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
6.3.3 Canada Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
6.3.4 Mexico Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2021-2032)
7.2 Europe Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2021-2032)
7.3 Europe Single-Use Technology for Biopharmaceuticals Market Size by Country
7.3.1 Europe Single-Use Technology for Biopharmaceuticals Consumption Value by Country (2021-2032)
7.3.2 Germany Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
7.3.3 France Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
7.3.5 Russia Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
7.3.6 Italy Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Single-Use Technology for Biopharmaceuticals Market Size by Region
8.3.1 Asia-Pacific Single-Use Technology for Biopharmaceuticals Consumption Value by Region (2021-2032)
8.3.2 China Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
8.3.3 Japan Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
8.3.4 South Korea Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
8.3.5 India Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
8.3.7 Australia Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2021-2032)
9.2 South America Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2021-2032)
9.3 South America Single-Use Technology for Biopharmaceuticals Market Size by Country
9.3.1 South America Single-Use Technology for Biopharmaceuticals Consumption Value by Country (2021-2032)
9.3.2 Brazil Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
9.3.3 Argentina Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Single-Use Technology for Biopharmaceuticals Market Size by Country
10.3.1 Middle East & Africa Single-Use Technology for Biopharmaceuticals Consumption Value by Country (2021-2032)
10.3.2 Turkey Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
10.3.4 UAE Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Single-Use Technology for Biopharmaceuticals Market Drivers
11.2 Single-Use Technology for Biopharmaceuticals Market Restraints
11.3 Single-Use Technology for Biopharmaceuticals Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Single-Use Technology for Biopharmaceuticals Industry Chain
12.2 Single-Use Technology for Biopharmaceuticals Upstream Analysis
12.3 Single-Use Technology for Biopharmaceuticals Midstream Analysis
12.4 Single-Use Technology for Biopharmaceuticals Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Single-Use Technology for Biopharmaceuticals by Type
1.3.1 Overview: Global Single-Use Technology for Biopharmaceuticals Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Type in 2025
1.3.3 Single-use Bioreactors
1.3.4 Single-use Bags & Containers
1.3.5 Filtration Assemblies
1.3.6 Tubing & Connectors
1.3.7 Others
1.4 Classification of Single-Use Technology for Biopharmaceuticals by End User
1.4.1 Overview: Global Single-Use Technology for Biopharmaceuticals Market Size by End User: 2021 Versus 2025 Versus 2032
1.4.2 Global Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by End User in 2025
1.4.3 Biopharmaceutical Companies
1.4.4 CDMOs / CMOs
1.4.5 Research Institutes
1.4.6 Cell & Gene Therapy Companies
1.4.7 Vaccine Manufacturers
1.5 Classification of Single-Use Technology for Biopharmaceuticals by Scale of Operation
1.5.1 Overview: Global Single-Use Technology for Biopharmaceuticals Market Size by Scale of Operation: 2021 Versus 2025 Versus 2032
1.5.2 Global Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Scale of Operation in 2025
1.5.3 <50 L
1.5.4 50?500 L
1.5.5 500?1,000 L
1.5.6 >1,000 L
1.6 Global Single-Use Technology for Biopharmaceuticals Market by Application
1.6.1 Overview: Global Single-Use Technology for Biopharmaceuticals Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Monoclonal Antibodies
1.6.3 Vaccines
1.6.4 Cell & Gene Therapy
1.6.5 Recombinant Proteins
1.6.6 Others
1.7 Global Single-Use Technology for Biopharmaceuticals Market Size & Forecast
1.8 Global Single-Use Technology for Biopharmaceuticals Market Size and Forecast by Region
1.8.1 Global Single-Use Technology for Biopharmaceuticals Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Single-Use Technology for Biopharmaceuticals Market Size by Region, (2021-2032)
1.8.3 North America Single-Use Technology for Biopharmaceuticals Market Size and Prospect (2021-2032)
1.8.4 Europe Single-Use Technology for Biopharmaceuticals Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Single-Use Technology for Biopharmaceuticals Market Size and Prospect (2021-2032)
1.8.6 South America Single-Use Technology for Biopharmaceuticals Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Single-Use Technology for Biopharmaceuticals Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Danaher (US)
2.1.1 Danaher (US) Details
2.1.2 Danaher (US) Major Business
2.1.3 Danaher (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.1.4 Danaher (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Danaher (US) Recent Developments and Future Plans
2.2 Sartorius (DE)
2.2.1 Sartorius (DE) Details
2.2.2 Sartorius (DE) Major Business
2.2.3 Sartorius (DE) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.2.4 Sartorius (DE) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Sartorius (DE) Recent Developments and Future Plans
2.3 Thermo Fisher Scientific (US)
2.3.1 Thermo Fisher Scientific (US) Details
2.3.2 Thermo Fisher Scientific (US) Major Business
2.3.3 Thermo Fisher Scientific (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.3.4 Thermo Fisher Scientific (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Thermo Fisher Scientific (US) Recent Developments and Future Plans
2.4 Merck KGaA (DE)
2.4.1 Merck KGaA (DE) Details
2.4.2 Merck KGaA (DE) Major Business
2.4.3 Merck KGaA (DE) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.4.4 Merck KGaA (DE) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Merck KGaA (DE) Recent Developments and Future Plans
2.5 Repligen (US)
2.5.1 Repligen (US) Details
2.5.2 Repligen (US) Major Business
2.5.3 Repligen (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.5.4 Repligen (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Repligen (US) Recent Developments and Future Plans
2.6 Meissner Filtration Products (US)
2.6.1 Meissner Filtration Products (US) Details
2.6.2 Meissner Filtration Products (US) Major Business
2.6.3 Meissner Filtration Products (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.6.4 Meissner Filtration Products (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Meissner Filtration Products (US) Recent Developments and Future Plans
2.7 ABEC (US)
2.7.1 ABEC (US) Details
2.7.2 ABEC (US) Major Business
2.7.3 ABEC (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.7.4 ABEC (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 ABEC (US) Recent Developments and Future Plans
2.8 Avantor (US)
2.8.1 Avantor (US) Details
2.8.2 Avantor (US) Major Business
2.8.3 Avantor (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.8.4 Avantor (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Avantor (US) Recent Developments and Future Plans
2.9 Corning (US)
2.9.1 Corning (US) Details
2.9.2 Corning (US) Major Business
2.9.3 Corning (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.9.4 Corning (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Corning (US) Recent Developments and Future Plans
2.10 Entegris (US)
2.10.1 Entegris (US) Details
2.10.2 Entegris (US) Major Business
2.10.3 Entegris (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.10.4 Entegris (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Entegris (US) Recent Developments and Future Plans
2.11 Saint-Gobain Life Sciences (FR)
2.11.1 Saint-Gobain Life Sciences (FR) Details
2.11.2 Saint-Gobain Life Sciences (FR) Major Business
2.11.3 Saint-Gobain Life Sciences (FR) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.11.4 Saint-Gobain Life Sciences (FR) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Saint-Gobain Life Sciences (FR) Recent Developments and Future Plans
2.12 Watson-Marlow / BioPure (GB)
2.12.1 Watson-Marlow / BioPure (GB) Details
2.12.2 Watson-Marlow / BioPure (GB) Major Business
2.12.3 Watson-Marlow / BioPure (GB) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.12.4 Watson-Marlow / BioPure (GB) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Watson-Marlow / BioPure (GB) Recent Developments and Future Plans
2.13 CPC / Colder Products (US)
2.13.1 CPC / Colder Products (US) Details
2.13.2 CPC / Colder Products (US) Major Business
2.13.3 CPC / Colder Products (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.13.4 CPC / Colder Products (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 CPC / Colder Products (US) Recent Developments and Future Plans
2.14 Eppendorf (DE)
2.14.1 Eppendorf (DE) Details
2.14.2 Eppendorf (DE) Major Business
2.14.3 Eppendorf (DE) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.14.4 Eppendorf (DE) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Eppendorf (DE) Recent Developments and Future Plans
2.15 Getinge / Applikon (SE)
2.15.1 Getinge / Applikon (SE) Details
2.15.2 Getinge / Applikon (SE) Major Business
2.15.3 Getinge / Applikon (SE) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.15.4 Getinge / Applikon (SE) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Getinge / Applikon (SE) Recent Developments and Future Plans
2.16 PBS Biotech (US)
2.16.1 PBS Biotech (US) Details
2.16.2 PBS Biotech (US) Major Business
2.16.3 PBS Biotech (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.16.4 PBS Biotech (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 PBS Biotech (US) Recent Developments and Future Plans
2.17 Shanghai Tofflon Science and Technology Co., Ltd. (CN)
2.17.1 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Details
2.17.2 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Major Business
2.17.3 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.17.4 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Recent Developments and Future Plans
2.18 Shanghai LePure Biotech Co., Ltd. (CN)
2.18.1 Shanghai LePure Biotech Co., Ltd. (CN) Details
2.18.2 Shanghai LePure Biotech Co., Ltd. (CN) Major Business
2.18.3 Shanghai LePure Biotech Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.18.4 Shanghai LePure Biotech Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Shanghai LePure Biotech Co., Ltd. (CN) Recent Developments and Future Plans
2.19 Shanghai Duoning Biotechnology Co., Ltd. (CN)
2.19.1 Shanghai Duoning Biotechnology Co., Ltd. (CN) Details
2.19.2 Shanghai Duoning Biotechnology Co., Ltd. (CN) Major Business
2.19.3 Shanghai Duoning Biotechnology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product and Solutions
2.19.4 Shanghai Duoning Biotechnology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Shanghai Duoning Biotechnology Co., Ltd. (CN) Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Single-Use Technology for Biopharmaceuticals Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Single-Use Technology for Biopharmaceuticals by Company Revenue
3.2.2 Top 3 Single-Use Technology for Biopharmaceuticals Players Market Share in 2025
3.2.3 Top 6 Single-Use Technology for Biopharmaceuticals Players Market Share in 2025
3.3 Single-Use Technology for Biopharmaceuticals Market: Overall Company Footprint Analysis
3.3.1 Single-Use Technology for Biopharmaceuticals Market: Region Footprint
3.3.2 Single-Use Technology for Biopharmaceuticals Market: Company Product Type Footprint
3.3.3 Single-Use Technology for Biopharmaceuticals Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Single-Use Technology for Biopharmaceuticals Consumption Value and Market Share by Type (2021-2026)
4.2 Global Single-Use Technology for Biopharmaceuticals Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Application (2021-2026)
5.2 Global Single-Use Technology for Biopharmaceuticals Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2021-2032)
6.2 North America Single-Use Technology for Biopharmaceuticals Market Size by Application (2021-2032)
6.3 North America Single-Use Technology for Biopharmaceuticals Market Size by Country
6.3.1 North America Single-Use Technology for Biopharmaceuticals Consumption Value by Country (2021-2032)
6.3.2 United States Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
6.3.3 Canada Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
6.3.4 Mexico Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2021-2032)
7.2 Europe Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2021-2032)
7.3 Europe Single-Use Technology for Biopharmaceuticals Market Size by Country
7.3.1 Europe Single-Use Technology for Biopharmaceuticals Consumption Value by Country (2021-2032)
7.3.2 Germany Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
7.3.3 France Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
7.3.5 Russia Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
7.3.6 Italy Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Single-Use Technology for Biopharmaceuticals Market Size by Region
8.3.1 Asia-Pacific Single-Use Technology for Biopharmaceuticals Consumption Value by Region (2021-2032)
8.3.2 China Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
8.3.3 Japan Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
8.3.4 South Korea Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
8.3.5 India Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
8.3.7 Australia Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2021-2032)
9.2 South America Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2021-2032)
9.3 South America Single-Use Technology for Biopharmaceuticals Market Size by Country
9.3.1 South America Single-Use Technology for Biopharmaceuticals Consumption Value by Country (2021-2032)
9.3.2 Brazil Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
9.3.3 Argentina Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Single-Use Technology for Biopharmaceuticals Market Size by Country
10.3.1 Middle East & Africa Single-Use Technology for Biopharmaceuticals Consumption Value by Country (2021-2032)
10.3.2 Turkey Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
10.3.4 UAE Single-Use Technology for Biopharmaceuticals Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Single-Use Technology for Biopharmaceuticals Market Drivers
11.2 Single-Use Technology for Biopharmaceuticals Market Restraints
11.3 Single-Use Technology for Biopharmaceuticals Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Single-Use Technology for Biopharmaceuticals Industry Chain
12.2 Single-Use Technology for Biopharmaceuticals Upstream Analysis
12.3 Single-Use Technology for Biopharmaceuticals Midstream Analysis
12.4 Single-Use Technology for Biopharmaceuticals Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Single-Use Technology for Biopharmaceuticals Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Single-Use Technology for Biopharmaceuticals Consumption Value by End User, (USD Million), 2021 & 2025 & 2032
Table 3. Global Single-Use Technology for Biopharmaceuticals Consumption Value by Scale of Operation, (USD Million), 2021 & 2025 & 2032
Table 4. Global Single-Use Technology for Biopharmaceuticals Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Single-Use Technology for Biopharmaceuticals Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Single-Use Technology for Biopharmaceuticals Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Danaher (US) Company Information, Head Office, and Major Competitors
Table 8. Danaher (US) Major Business
Table 9. Danaher (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 10. Danaher (US) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Danaher (US) Recent Developments and Future Plans
Table 12. Sartorius (DE) Company Information, Head Office, and Major Competitors
Table 13. Sartorius (DE) Major Business
Table 14. Sartorius (DE) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 15. Sartorius (DE) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Sartorius (DE) Recent Developments and Future Plans
Table 17. Thermo Fisher Scientific (US) Company Information, Head Office, and Major Competitors
Table 18. Thermo Fisher Scientific (US) Major Business
Table 19. Thermo Fisher Scientific (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 20. Thermo Fisher Scientific (US) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Merck KGaA (DE) Company Information, Head Office, and Major Competitors
Table 22. Merck KGaA (DE) Major Business
Table 23. Merck KGaA (DE) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 24. Merck KGaA (DE) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Merck KGaA (DE) Recent Developments and Future Plans
Table 26. Repligen (US) Company Information, Head Office, and Major Competitors
Table 27. Repligen (US) Major Business
Table 28. Repligen (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 29. Repligen (US) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Repligen (US) Recent Developments and Future Plans
Table 31. Meissner Filtration Products (US) Company Information, Head Office, and Major Competitors
Table 32. Meissner Filtration Products (US) Major Business
Table 33. Meissner Filtration Products (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 34. Meissner Filtration Products (US) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Meissner Filtration Products (US) Recent Developments and Future Plans
Table 36. ABEC (US) Company Information, Head Office, and Major Competitors
Table 37. ABEC (US) Major Business
Table 38. ABEC (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 39. ABEC (US) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. ABEC (US) Recent Developments and Future Plans
Table 41. Avantor (US) Company Information, Head Office, and Major Competitors
Table 42. Avantor (US) Major Business
Table 43. Avantor (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 44. Avantor (US) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Avantor (US) Recent Developments and Future Plans
Table 46. Corning (US) Company Information, Head Office, and Major Competitors
Table 47. Corning (US) Major Business
Table 48. Corning (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 49. Corning (US) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Corning (US) Recent Developments and Future Plans
Table 51. Entegris (US) Company Information, Head Office, and Major Competitors
Table 52. Entegris (US) Major Business
Table 53. Entegris (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 54. Entegris (US) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Entegris (US) Recent Developments and Future Plans
Table 56. Saint-Gobain Life Sciences (FR) Company Information, Head Office, and Major Competitors
Table 57. Saint-Gobain Life Sciences (FR) Major Business
Table 58. Saint-Gobain Life Sciences (FR) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 59. Saint-Gobain Life Sciences (FR) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Saint-Gobain Life Sciences (FR) Recent Developments and Future Plans
Table 61. Watson-Marlow / BioPure (GB) Company Information, Head Office, and Major Competitors
Table 62. Watson-Marlow / BioPure (GB) Major Business
Table 63. Watson-Marlow / BioPure (GB) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 64. Watson-Marlow / BioPure (GB) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Watson-Marlow / BioPure (GB) Recent Developments and Future Plans
Table 66. CPC / Colder Products (US) Company Information, Head Office, and Major Competitors
Table 67. CPC / Colder Products (US) Major Business
Table 68. CPC / Colder Products (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 69. CPC / Colder Products (US) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. CPC / Colder Products (US) Recent Developments and Future Plans
Table 71. Eppendorf (DE) Company Information, Head Office, and Major Competitors
Table 72. Eppendorf (DE) Major Business
Table 73. Eppendorf (DE) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 74. Eppendorf (DE) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Eppendorf (DE) Recent Developments and Future Plans
Table 76. Getinge / Applikon (SE) Company Information, Head Office, and Major Competitors
Table 77. Getinge / Applikon (SE) Major Business
Table 78. Getinge / Applikon (SE) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 79. Getinge / Applikon (SE) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Getinge / Applikon (SE) Recent Developments and Future Plans
Table 81. PBS Biotech (US) Company Information, Head Office, and Major Competitors
Table 82. PBS Biotech (US) Major Business
Table 83. PBS Biotech (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 84. PBS Biotech (US) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. PBS Biotech (US) Recent Developments and Future Plans
Table 86. Shanghai Tofflon Science and Technology Co., Ltd. (CN) Company Information, Head Office, and Major Competitors
Table 87. Shanghai Tofflon Science and Technology Co., Ltd. (CN) Major Business
Table 88. Shanghai Tofflon Science and Technology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 89. Shanghai Tofflon Science and Technology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Shanghai Tofflon Science and Technology Co., Ltd. (CN) Recent Developments and Future Plans
Table 91. Shanghai LePure Biotech Co., Ltd. (CN) Company Information, Head Office, and Major Competitors
Table 92. Shanghai LePure Biotech Co., Ltd. (CN) Major Business
Table 93. Shanghai LePure Biotech Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 94. Shanghai LePure Biotech Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Shanghai LePure Biotech Co., Ltd. (CN) Recent Developments and Future Plans
Table 96. Shanghai Duoning Biotechnology Co., Ltd. (CN) Company Information, Head Office, and Major Competitors
Table 97. Shanghai Duoning Biotechnology Co., Ltd. (CN) Major Business
Table 98. Shanghai Duoning Biotechnology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 99. Shanghai Duoning Biotechnology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. Shanghai Duoning Biotechnology Co., Ltd. (CN) Recent Developments and Future Plans
Table 101. Global Single-Use Technology for Biopharmaceuticals Revenue (USD Million) by Players (2021-2026)
Table 102. Global Single-Use Technology for Biopharmaceuticals Revenue Share by Players (2021-2026)
Table 103. Breakdown of Single-Use Technology for Biopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3)
Table 104. Market Position of Players in Single-Use Technology for Biopharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 105. Head Office of Key Single-Use Technology for Biopharmaceuticals Players
Table 106. Single-Use Technology for Biopharmaceuticals Market: Company Product Type Footprint
Table 107. Single-Use Technology for Biopharmaceuticals Market: Company Product Application Footprint
Table 108. Single-Use Technology for Biopharmaceuticals New Market Entrants and Barriers to Market Entry
Table 109. Single-Use Technology for Biopharmaceuticals Mergers, Acquisition, Agreements, and Collaborations
Table 110. Global Single-Use Technology for Biopharmaceuticals Consumption Value (USD Million) by Type (2021-2026)
Table 111. Global Single-Use Technology for Biopharmaceuticals Consumption Value Share by Type (2021-2026)
Table 112. Global Single-Use Technology for Biopharmaceuticals Consumption Value Forecast by Type (2027-2032)
Table 113. Global Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2021-2026)
Table 114. Global Single-Use Technology for Biopharmaceuticals Consumption Value Forecast by Application (2027-2032)
Table 115. North America Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2021-2026) & (USD Million)
Table 116. North America Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2027-2032) & (USD Million)
Table 117. North America Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2021-2026) & (USD Million)
Table 118. North America Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2027-2032) & (USD Million)
Table 119. North America Single-Use Technology for Biopharmaceuticals Consumption Value by Country (2021-2026) & (USD Million)
Table 120. North America Single-Use Technology for Biopharmaceuticals Consumption Value by Country (2027-2032) & (USD Million)
Table 121. Europe Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2021-2026) & (USD Million)
Table 122. Europe Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2027-2032) & (USD Million)
Table 123. Europe Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2021-2026) & (USD Million)
Table 124. Europe Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2027-2032) & (USD Million)
Table 125. Europe Single-Use Technology for Biopharmaceuticals Consumption Value by Country (2021-2026) & (USD Million)
Table 126. Europe Single-Use Technology for Biopharmaceuticals Consumption Value by Country (2027-2032) & (USD Million)
Table 127. Asia-Pacific Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2021-2026) & (USD Million)
Table 128. Asia-Pacific Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2027-2032) & (USD Million)
Table 129. Asia-Pacific Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2021-2026) & (USD Million)
Table 130. Asia-Pacific Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2027-2032) & (USD Million)
Table 131. Asia-Pacific Single-Use Technology for Biopharmaceuticals Consumption Value by Region (2021-2026) & (USD Million)
Table 132. Asia-Pacific Single-Use Technology for Biopharmaceuticals Consumption Value by Region (2027-2032) & (USD Million)
Table 133. South America Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2021-2026) & (USD Million)
Table 134. South America Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2027-2032) & (USD Million)
Table 135. South America Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2021-2026) & (USD Million)
Table 136. South America Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2027-2032) & (USD Million)
Table 137. South America Single-Use Technology for Biopharmaceuticals Consumption Value by Country (2021-2026) & (USD Million)
Table 138. South America Single-Use Technology for Biopharmaceuticals Consumption Value by Country (2027-2032) & (USD Million)
Table 139. Middle East & Africa Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2021-2026) & (USD Million)
Table 140. Middle East & Africa Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2027-2032) & (USD Million)
Table 141. Middle East & Africa Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2021-2026) & (USD Million)
Table 142. Middle East & Africa Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2027-2032) & (USD Million)
Table 143. Middle East & Africa Single-Use Technology for Biopharmaceuticals Consumption Value by Country (2021-2026) & (USD Million)
Table 144. Middle East & Africa Single-Use Technology for Biopharmaceuticals Consumption Value by Country (2027-2032) & (USD Million)
Table 145. Global Key Players of Single-Use Technology for Biopharmaceuticals Upstream (Raw Materials)
Table 146. Global Single-Use Technology for Biopharmaceuticals Typical Customers
Table 1. Global Single-Use Technology for Biopharmaceuticals Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Single-Use Technology for Biopharmaceuticals Consumption Value by End User, (USD Million), 2021 & 2025 & 2032
Table 3. Global Single-Use Technology for Biopharmaceuticals Consumption Value by Scale of Operation, (USD Million), 2021 & 2025 & 2032
Table 4. Global Single-Use Technology for Biopharmaceuticals Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Single-Use Technology for Biopharmaceuticals Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Single-Use Technology for Biopharmaceuticals Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Danaher (US) Company Information, Head Office, and Major Competitors
Table 8. Danaher (US) Major Business
Table 9. Danaher (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 10. Danaher (US) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Danaher (US) Recent Developments and Future Plans
Table 12. Sartorius (DE) Company Information, Head Office, and Major Competitors
Table 13. Sartorius (DE) Major Business
Table 14. Sartorius (DE) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 15. Sartorius (DE) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Sartorius (DE) Recent Developments and Future Plans
Table 17. Thermo Fisher Scientific (US) Company Information, Head Office, and Major Competitors
Table 18. Thermo Fisher Scientific (US) Major Business
Table 19. Thermo Fisher Scientific (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 20. Thermo Fisher Scientific (US) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Merck KGaA (DE) Company Information, Head Office, and Major Competitors
Table 22. Merck KGaA (DE) Major Business
Table 23. Merck KGaA (DE) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 24. Merck KGaA (DE) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Merck KGaA (DE) Recent Developments and Future Plans
Table 26. Repligen (US) Company Information, Head Office, and Major Competitors
Table 27. Repligen (US) Major Business
Table 28. Repligen (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 29. Repligen (US) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Repligen (US) Recent Developments and Future Plans
Table 31. Meissner Filtration Products (US) Company Information, Head Office, and Major Competitors
Table 32. Meissner Filtration Products (US) Major Business
Table 33. Meissner Filtration Products (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 34. Meissner Filtration Products (US) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Meissner Filtration Products (US) Recent Developments and Future Plans
Table 36. ABEC (US) Company Information, Head Office, and Major Competitors
Table 37. ABEC (US) Major Business
Table 38. ABEC (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 39. ABEC (US) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. ABEC (US) Recent Developments and Future Plans
Table 41. Avantor (US) Company Information, Head Office, and Major Competitors
Table 42. Avantor (US) Major Business
Table 43. Avantor (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 44. Avantor (US) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Avantor (US) Recent Developments and Future Plans
Table 46. Corning (US) Company Information, Head Office, and Major Competitors
Table 47. Corning (US) Major Business
Table 48. Corning (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 49. Corning (US) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Corning (US) Recent Developments and Future Plans
Table 51. Entegris (US) Company Information, Head Office, and Major Competitors
Table 52. Entegris (US) Major Business
Table 53. Entegris (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 54. Entegris (US) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Entegris (US) Recent Developments and Future Plans
Table 56. Saint-Gobain Life Sciences (FR) Company Information, Head Office, and Major Competitors
Table 57. Saint-Gobain Life Sciences (FR) Major Business
Table 58. Saint-Gobain Life Sciences (FR) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 59. Saint-Gobain Life Sciences (FR) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Saint-Gobain Life Sciences (FR) Recent Developments and Future Plans
Table 61. Watson-Marlow / BioPure (GB) Company Information, Head Office, and Major Competitors
Table 62. Watson-Marlow / BioPure (GB) Major Business
Table 63. Watson-Marlow / BioPure (GB) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 64. Watson-Marlow / BioPure (GB) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Watson-Marlow / BioPure (GB) Recent Developments and Future Plans
Table 66. CPC / Colder Products (US) Company Information, Head Office, and Major Competitors
Table 67. CPC / Colder Products (US) Major Business
Table 68. CPC / Colder Products (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 69. CPC / Colder Products (US) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. CPC / Colder Products (US) Recent Developments and Future Plans
Table 71. Eppendorf (DE) Company Information, Head Office, and Major Competitors
Table 72. Eppendorf (DE) Major Business
Table 73. Eppendorf (DE) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 74. Eppendorf (DE) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Eppendorf (DE) Recent Developments and Future Plans
Table 76. Getinge / Applikon (SE) Company Information, Head Office, and Major Competitors
Table 77. Getinge / Applikon (SE) Major Business
Table 78. Getinge / Applikon (SE) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 79. Getinge / Applikon (SE) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Getinge / Applikon (SE) Recent Developments and Future Plans
Table 81. PBS Biotech (US) Company Information, Head Office, and Major Competitors
Table 82. PBS Biotech (US) Major Business
Table 83. PBS Biotech (US) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 84. PBS Biotech (US) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. PBS Biotech (US) Recent Developments and Future Plans
Table 86. Shanghai Tofflon Science and Technology Co., Ltd. (CN) Company Information, Head Office, and Major Competitors
Table 87. Shanghai Tofflon Science and Technology Co., Ltd. (CN) Major Business
Table 88. Shanghai Tofflon Science and Technology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 89. Shanghai Tofflon Science and Technology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Shanghai Tofflon Science and Technology Co., Ltd. (CN) Recent Developments and Future Plans
Table 91. Shanghai LePure Biotech Co., Ltd. (CN) Company Information, Head Office, and Major Competitors
Table 92. Shanghai LePure Biotech Co., Ltd. (CN) Major Business
Table 93. Shanghai LePure Biotech Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 94. Shanghai LePure Biotech Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Shanghai LePure Biotech Co., Ltd. (CN) Recent Developments and Future Plans
Table 96. Shanghai Duoning Biotechnology Co., Ltd. (CN) Company Information, Head Office, and Major Competitors
Table 97. Shanghai Duoning Biotechnology Co., Ltd. (CN) Major Business
Table 98. Shanghai Duoning Biotechnology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product and Solutions
Table 99. Shanghai Duoning Biotechnology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. Shanghai Duoning Biotechnology Co., Ltd. (CN) Recent Developments and Future Plans
Table 101. Global Single-Use Technology for Biopharmaceuticals Revenue (USD Million) by Players (2021-2026)
Table 102. Global Single-Use Technology for Biopharmaceuticals Revenue Share by Players (2021-2026)
Table 103. Breakdown of Single-Use Technology for Biopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3)
Table 104. Market Position of Players in Single-Use Technology for Biopharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 105. Head Office of Key Single-Use Technology for Biopharmaceuticals Players
Table 106. Single-Use Technology for Biopharmaceuticals Market: Company Product Type Footprint
Table 107. Single-Use Technology for Biopharmaceuticals Market: Company Product Application Footprint
Table 108. Single-Use Technology for Biopharmaceuticals New Market Entrants and Barriers to Market Entry
Table 109. Single-Use Technology for Biopharmaceuticals Mergers, Acquisition, Agreements, and Collaborations
Table 110. Global Single-Use Technology for Biopharmaceuticals Consumption Value (USD Million) by Type (2021-2026)
Table 111. Global Single-Use Technology for Biopharmaceuticals Consumption Value Share by Type (2021-2026)
Table 112. Global Single-Use Technology for Biopharmaceuticals Consumption Value Forecast by Type (2027-2032)
Table 113. Global Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2021-2026)
Table 114. Global Single-Use Technology for Biopharmaceuticals Consumption Value Forecast by Application (2027-2032)
Table 115. North America Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2021-2026) & (USD Million)
Table 116. North America Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2027-2032) & (USD Million)
Table 117. North America Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2021-2026) & (USD Million)
Table 118. North America Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2027-2032) & (USD Million)
Table 119. North America Single-Use Technology for Biopharmaceuticals Consumption Value by Country (2021-2026) & (USD Million)
Table 120. North America Single-Use Technology for Biopharmaceuticals Consumption Value by Country (2027-2032) & (USD Million)
Table 121. Europe Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2021-2026) & (USD Million)
Table 122. Europe Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2027-2032) & (USD Million)
Table 123. Europe Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2021-2026) & (USD Million)
Table 124. Europe Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2027-2032) & (USD Million)
Table 125. Europe Single-Use Technology for Biopharmaceuticals Consumption Value by Country (2021-2026) & (USD Million)
Table 126. Europe Single-Use Technology for Biopharmaceuticals Consumption Value by Country (2027-2032) & (USD Million)
Table 127. Asia-Pacific Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2021-2026) & (USD Million)
Table 128. Asia-Pacific Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2027-2032) & (USD Million)
Table 129. Asia-Pacific Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2021-2026) & (USD Million)
Table 130. Asia-Pacific Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2027-2032) & (USD Million)
Table 131. Asia-Pacific Single-Use Technology for Biopharmaceuticals Consumption Value by Region (2021-2026) & (USD Million)
Table 132. Asia-Pacific Single-Use Technology for Biopharmaceuticals Consumption Value by Region (2027-2032) & (USD Million)
Table 133. South America Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2021-2026) & (USD Million)
Table 134. South America Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2027-2032) & (USD Million)
Table 135. South America Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2021-2026) & (USD Million)
Table 136. South America Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2027-2032) & (USD Million)
Table 137. South America Single-Use Technology for Biopharmaceuticals Consumption Value by Country (2021-2026) & (USD Million)
Table 138. South America Single-Use Technology for Biopharmaceuticals Consumption Value by Country (2027-2032) & (USD Million)
Table 139. Middle East & Africa Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2021-2026) & (USD Million)
Table 140. Middle East & Africa Single-Use Technology for Biopharmaceuticals Consumption Value by Type (2027-2032) & (USD Million)
Table 141. Middle East & Africa Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2021-2026) & (USD Million)
Table 142. Middle East & Africa Single-Use Technology for Biopharmaceuticals Consumption Value by Application (2027-2032) & (USD Million)
Table 143. Middle East & Africa Single-Use Technology for Biopharmaceuticals Consumption Value by Country (2021-2026) & (USD Million)
Table 144. Middle East & Africa Single-Use Technology for Biopharmaceuticals Consumption Value by Country (2027-2032) & (USD Million)
Table 145. Global Key Players of Single-Use Technology for Biopharmaceuticals Upstream (Raw Materials)
Table 146. Global Single-Use Technology for Biopharmaceuticals Typical Customers
LIST OF FIGURES
Figure 1. Single-Use Technology for Biopharmaceuticals Picture
Figure 2. Global Single-Use Technology for Biopharmaceuticals Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Type in 2025
Figure 4. Single-use Bioreactors
Figure 5. Single-use Bags & Containers
Figure 6. Filtration Assemblies
Figure 7. Tubing & Connectors
Figure 8. Others
Figure 9. Global Single-Use Technology for Biopharmaceuticals Consumption Value by End User, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by End User in 2025
Figure 11. Biopharmaceutical Companies
Figure 12. CDMOs / CMOs
Figure 13. Research Institutes
Figure 14. Cell & Gene Therapy Companies
Figure 15. Vaccine Manufacturers
Figure 16. Global Single-Use Technology for Biopharmaceuticals Consumption Value by Scale of Operation, (USD Million), 2021 & 2025 & 2032
Figure 17. Global Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Scale of Operation in 2025
Figure 18. <50 L
Figure 19. 50?500 L
Figure 20. 500?1,000 L
Figure 21. >1,000 L
Figure 22. Global Single-Use Technology for Biopharmaceuticals Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 23. Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Application in 2025
Figure 24. Monoclonal Antibodies Picture
Figure 25. Vaccines Picture
Figure 26. Cell & Gene Therapy Picture
Figure 27. Recombinant Proteins Picture
Figure 28. Others Picture
Figure 29. Global Single-Use Technology for Biopharmaceuticals Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 30. Global Single-Use Technology for Biopharmaceuticals Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 31. Global Market Single-Use Technology for Biopharmaceuticals Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 32. Global Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Region (2021-2032)
Figure 33. Global Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Region in 2025
Figure 34. North America Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 35. Europe Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 36. Asia-Pacific Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 37. South America Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 38. Middle East & Africa Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 39. Company Three Recent Developments and Future Plans
Figure 40. Global Single-Use Technology for Biopharmaceuticals Revenue Share by Players in 2025
Figure 41. Single-Use Technology for Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 42. Market Share of Single-Use Technology for Biopharmaceuticals by Player Revenue in 2025
Figure 43. Top 3 Single-Use Technology for Biopharmaceuticals Players Market Share in 2025
Figure 44. Top 6 Single-Use Technology for Biopharmaceuticals Players Market Share in 2025
Figure 45. Global Single-Use Technology for Biopharmaceuticals Consumption Value Share by Type (2021-2026)
Figure 46. Global Single-Use Technology for Biopharmaceuticals Market Share Forecast by Type (2027-2032)
Figure 47. Global Single-Use Technology for Biopharmaceuticals Consumption Value Share by Application (2021-2026)
Figure 48. Global Single-Use Technology for Biopharmaceuticals Market Share Forecast by Application (2027-2032)
Figure 49. North America Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Type (2021-2032)
Figure 50. North America Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Application (2021-2032)
Figure 51. North America Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Country (2021-2032)
Figure 52. United States Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 53. Canada Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 54. Mexico Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 55. Europe Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Type (2021-2032)
Figure 56. Europe Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Application (2021-2032)
Figure 57. Europe Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Country (2021-2032)
Figure 58. Germany Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 59. France Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 60. United Kingdom Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 61. Russia Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 62. Italy Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 63. Asia-Pacific Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Type (2021-2032)
Figure 64. Asia-Pacific Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Application (2021-2032)
Figure 65. Asia-Pacific Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Region (2021-2032)
Figure 66. China Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 67. Japan Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 68. South Korea Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 69. India Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 70. Southeast Asia Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 71. Australia Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 72. South America Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Type (2021-2032)
Figure 73. South America Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Application (2021-2032)
Figure 74. South America Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Country (2021-2032)
Figure 75. Brazil Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 76. Argentina Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 77. Middle East & Africa Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Type (2021-2032)
Figure 78. Middle East & Africa Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Application (2021-2032)
Figure 79. Middle East & Africa Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Country (2021-2032)
Figure 80. Turkey Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 81. Saudi Arabia Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 82. UAE Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 83. Single-Use Technology for Biopharmaceuticals Market Drivers
Figure 84. Single-Use Technology for Biopharmaceuticals Market Restraints
Figure 85. Single-Use Technology for Biopharmaceuticals Market Trends
Figure 86. Porters Five Forces Analysis
Figure 87. Single-Use Technology for Biopharmaceuticals Industrial Chain
Figure 88. Methodology
Figure 89. Research Process and Data Source
Figure 1. Single-Use Technology for Biopharmaceuticals Picture
Figure 2. Global Single-Use Technology for Biopharmaceuticals Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Type in 2025
Figure 4. Single-use Bioreactors
Figure 5. Single-use Bags & Containers
Figure 6. Filtration Assemblies
Figure 7. Tubing & Connectors
Figure 8. Others
Figure 9. Global Single-Use Technology for Biopharmaceuticals Consumption Value by End User, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by End User in 2025
Figure 11. Biopharmaceutical Companies
Figure 12. CDMOs / CMOs
Figure 13. Research Institutes
Figure 14. Cell & Gene Therapy Companies
Figure 15. Vaccine Manufacturers
Figure 16. Global Single-Use Technology for Biopharmaceuticals Consumption Value by Scale of Operation, (USD Million), 2021 & 2025 & 2032
Figure 17. Global Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Scale of Operation in 2025
Figure 18. <50 L
Figure 19. 50?500 L
Figure 20. 500?1,000 L
Figure 21. >1,000 L
Figure 22. Global Single-Use Technology for Biopharmaceuticals Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 23. Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Application in 2025
Figure 24. Monoclonal Antibodies Picture
Figure 25. Vaccines Picture
Figure 26. Cell & Gene Therapy Picture
Figure 27. Recombinant Proteins Picture
Figure 28. Others Picture
Figure 29. Global Single-Use Technology for Biopharmaceuticals Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 30. Global Single-Use Technology for Biopharmaceuticals Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 31. Global Market Single-Use Technology for Biopharmaceuticals Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 32. Global Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Region (2021-2032)
Figure 33. Global Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Region in 2025
Figure 34. North America Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 35. Europe Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 36. Asia-Pacific Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 37. South America Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 38. Middle East & Africa Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 39. Company Three Recent Developments and Future Plans
Figure 40. Global Single-Use Technology for Biopharmaceuticals Revenue Share by Players in 2025
Figure 41. Single-Use Technology for Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 42. Market Share of Single-Use Technology for Biopharmaceuticals by Player Revenue in 2025
Figure 43. Top 3 Single-Use Technology for Biopharmaceuticals Players Market Share in 2025
Figure 44. Top 6 Single-Use Technology for Biopharmaceuticals Players Market Share in 2025
Figure 45. Global Single-Use Technology for Biopharmaceuticals Consumption Value Share by Type (2021-2026)
Figure 46. Global Single-Use Technology for Biopharmaceuticals Market Share Forecast by Type (2027-2032)
Figure 47. Global Single-Use Technology for Biopharmaceuticals Consumption Value Share by Application (2021-2026)
Figure 48. Global Single-Use Technology for Biopharmaceuticals Market Share Forecast by Application (2027-2032)
Figure 49. North America Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Type (2021-2032)
Figure 50. North America Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Application (2021-2032)
Figure 51. North America Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Country (2021-2032)
Figure 52. United States Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 53. Canada Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 54. Mexico Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 55. Europe Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Type (2021-2032)
Figure 56. Europe Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Application (2021-2032)
Figure 57. Europe Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Country (2021-2032)
Figure 58. Germany Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 59. France Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 60. United Kingdom Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 61. Russia Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 62. Italy Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 63. Asia-Pacific Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Type (2021-2032)
Figure 64. Asia-Pacific Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Application (2021-2032)
Figure 65. Asia-Pacific Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Region (2021-2032)
Figure 66. China Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 67. Japan Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 68. South Korea Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 69. India Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 70. Southeast Asia Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 71. Australia Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 72. South America Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Type (2021-2032)
Figure 73. South America Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Application (2021-2032)
Figure 74. South America Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Country (2021-2032)
Figure 75. Brazil Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 76. Argentina Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 77. Middle East & Africa Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Type (2021-2032)
Figure 78. Middle East & Africa Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Application (2021-2032)
Figure 79. Middle East & Africa Single-Use Technology for Biopharmaceuticals Consumption Value Market Share by Country (2021-2032)
Figure 80. Turkey Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 81. Saudi Arabia Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 82. UAE Single-Use Technology for Biopharmaceuticals Consumption Value (2021-2032) & (USD Million)
Figure 83. Single-Use Technology for Biopharmaceuticals Market Drivers
Figure 84. Single-Use Technology for Biopharmaceuticals Market Restraints
Figure 85. Single-Use Technology for Biopharmaceuticals Market Trends
Figure 86. Porters Five Forces Analysis
Figure 87. Single-Use Technology for Biopharmaceuticals Industrial Chain
Figure 88. Methodology
Figure 89. Research Process and Data Source
